On the other hand, imatinib and nilotinib are also reported to induce apoptosis in BCR-ABL– cells of lymphoid origin [13] and are used for treatment of other types of cancer, such as advanced gastrointestinal stromal tumors [14]. The gene discussed is ABL1; the disease is cancer.